Thyroid News
New Hypothyroidism Treatment Guidelines from American Thyroid Association Published in Thyroid Journal

New Rochelle, NY, September 30, 2014—Levothyroxine (L-T4), long the standard of care for treating hypothyroidism, is effective in most patients, but some individuals do not regain optimal health on L-T4 monotherapy. New knowledge about thyroid physiology may help to explain these differences. An expert task force of the American Thyroid Association on thyroid hormone replacement reviewed the latest studies on L-T4 therapy and on alternative treatments to determine whether a change to the current standard of care is appropriate, and they present their recommendations in the article “Guidelines for the Treatment of Hypothyroidism,” published in Thyroid, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers and the official journal of the American Thyroid Association (ATA). The Guidelines are available free on the Thyroid website. Read More…

Clinical Thyroidology – Highlighted Article

From Clinical Thyroidology:  The Time Lag between Initiation of Amiodarone Treatment and First Evidence of Amiodarone —Induced Thyrotoxicosis Is a Useful Indicator for Identifying the Type of Hyperthyroidism – Hyperthyroidism and hypothyroidism are frequent complications of amiodarone treatment. One of these two complications will develop in 15% to 20% of patients treated with amiodarone….

Clinical Thyroidology for the Public – highlighted article

From Clinical Thyroidology for the Public: Thyroid cancer in survivors of Hodgkin’s lymphomaHistory of radiation to the head/neck region is known to be a risk factor for the development of thyroid cancer since the thyroid is directly exposed to the radiation …

Thyroid Highlighted Article

What Are the Psychosocial Outcomes of Treatment for Thyroid Eye Disease? A Systematic Review  Background:  Thyroid eye disease (TED) causes a number of esthetic and visual problems, and its treatment requires close clinical assessment, often for several years. There is evidence to suggest that clinical factors are poor indicators of patient-reported outcomes after treatments that aim to improve appearance, vision, or both.